Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 965 | 813 | 1,295 | 681 | 813 |
| Operating Income | -965 | -813 | -1,295 | -681 | -813 |
| Other Income | -4 | 20 | -8 | -7 | 9 |
| Pre-tax Income | -968 | -793 | -1,303 | -687 | -805 |
| Net Income Continuous | -968 | -793 | -1,303 | -687 | -805 |
| Net Income | $-968 | $-793 | $-1,303 | $-687 | $-805 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.05 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.05 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.05 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.05 | -0.03 | -0.03 |
| EBITDA(a) | $-964 | $-812 | $-1,294 | $-679 | $-812 |